Paul Juang

Summary

Affiliation: St. Louis College of Pharmacy
Country: USA

Publications

  1. ncbi request reprint Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation
    Paul Juang
    Department of Pharmacy Practice, St Louis College of Pharmacy, St Louis, Missouri 63110 1088, USA
    Pharmacotherapy 27:11-9. 2007
  2. ncbi request reprint Update on new antifungal therapy
    Paul Juang
    Department of Pharmacy Practice, St Louis College of Pharmacy, 4588 Parkview Place, St Louis, MO 63110, USA
    AACN Adv Crit Care 18:253-60; quiz 261-2. 2007
  3. doi request reprint Role of fidaxomicin for the treatment of Clostridium difficile infection
    Paul Juang
    Department of Pharmacy Practice, St Louis College of Pharmacy, St Louis, MO, USA
    J Pharm Pract 26:491-7. 2013
  4. doi request reprint The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*
    Andrew Labelle
    Division of Pulmonary and Critical Care, Washington University School of Medicine, St Louis, MO, USA
    Crit Care Med 40:2016-21. 2012
  5. ncbi request reprint Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea
    Paul Juang
    Department of Pharmacy and Therapeutics, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA
    Am J Infect Control 35:131-7. 2007

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation
    Paul Juang
    Department of Pharmacy Practice, St Louis College of Pharmacy, St Louis, Missouri 63110 1088, USA
    Pharmacotherapy 27:11-9. 2007
    ....
  2. ncbi request reprint Update on new antifungal therapy
    Paul Juang
    Department of Pharmacy Practice, St Louis College of Pharmacy, 4588 Parkview Place, St Louis, MO 63110, USA
    AACN Adv Crit Care 18:253-60; quiz 261-2. 2007
    ..Other considerations, such as precautions, administration techniques, potential drug interactions, and common adverse effects associated with the use of these agents, are also reviewed...
  3. doi request reprint Role of fidaxomicin for the treatment of Clostridium difficile infection
    Paul Juang
    Department of Pharmacy Practice, St Louis College of Pharmacy, St Louis, MO, USA
    J Pharm Pract 26:491-7. 2013
    ..Fidaxomicin appears to have a role in the treatment of CDI with potential lower rates of recurrence, especially in patients with severe disease or risk factors for recurrent CDI. ..
  4. doi request reprint The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*
    Andrew Labelle
    Division of Pulmonary and Critical Care, Washington University School of Medicine, St Louis, MO, USA
    Crit Care Med 40:2016-21. 2012
    ..To identify the determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment...
  5. ncbi request reprint Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea
    Paul Juang
    Department of Pharmacy and Therapeutics, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA
    Am J Infect Control 35:131-7. 2007
    ....